Nathalie Baïda

Played a key role in expanding Amgen's institutional footprint in Quebec, forging strategic partnerships with senior decision-makers and aligning innovative GI solutions with healthcare priorities to position Amgen as a trusted partner in the GI space for our biosimilars portfolio

Drove 60% of provincial sales and contributed 30% to national sales for Ustekinumab.

• Conducted an extensive Gastroenterology market analysis to support the successful launch of Wezlana (Ustekinumab), identifying key institutional opportunities. Leveraged market insights and KOL partnerships to deliver mutually beneficial outcomes.
• Developed comprehensive account plans, led cross-functional collaboration, and successfully executed targeted engagement strategies.
• Successfully implemented alignment of Patient Support Programs (PSP) with customers and suppliers, enhancing collaboration and significantly improving operational efficiency.

Co-created value based partnerships with Retirement home / LTC c-suite executives, significantly enhancing institutional stakeholder engagement across Quebec

Identified customer-centric business opportunities, executed strategic account plans and drove sales working with multiple customer groups (physicians, pharmacists, nurses, C-suites) on fracture prevention and osteoporosis risk management to differentiate Amgen and drive business

• 2019: Intercontinental Value-Based Partnership winning idea for Canada
• 2020: Global Winner of the best-in-class Value Based Partnership
• 2022: Team Collaboration Excellence Award
• Developed a network of KOL and trusted advisors to drive advocacy and sales: 12 LTC central-fill pharmacies / driving year-over-year average growth 20-30%
• Drove targeted high prescriber adoption in 120-140 key accounts to ensure optimal & safe use of OP treatment options and continuum of care in seniors at high risk for fractures

• Led and developed a PSP vision and broad strategies for 6 innovative Oncology brands to drive strategic improvements of the operation plans, budget, SOWs, MSA and execution of new patient program offerings
• Supported field teams with strong communication and timely customer service to address customer needs
• Led the pharmacovigilance program to ensure process is in place for identifying and reporting safety information

• Led and managed marketing strategy for IBAVYR (ribavirin) - first stand-alone oral add on treatment for hepatitis C virus to leading GILEAD product (Sovaldi)
• Developed and implemented marketing plan strategy to maximize product end of life cycle in declining market
• Exceeded forecast and effectively managed A&P budget to deliver plan by achieving 140% of target sales at the end of fiscal year 2016
• Guided sales managers, medical and sales team to execute on TREAT NOW marketing strategy to maximize revenues before Gilead break through single dose high cure rates therapy hits the market

Led Patient Support Programs (PSP) in Ophthalmology, designing and executing tailored marketing initiatives and patient solutions informed by customer insights and market research.

• Directed cross-functional teams to align PSP initiatives with brand strategies, enhancing patient outcomes and market performance.
• Developed and implemented strategic sales training, comprehensive PSP staff curricula, and managed PSP communications and operations, including hiring and coaching case managers and nurses.
• Pioneered innovative solutions such as in-clinic nurse assistance, reimbursement programs, and a bridging program enabling immediate patient treatment prior to insurance approval.

Key Achievements :

• Achieved a 21% increase in patient enrollment through the First Dose Program within six months of launch, generating over $10M in additional sales.
• 2013 Commercial Excellence Award (Customer & Patient Focus)
• 2014 Brand Maximization award finalist

Developed strong strategic partnerships with key long-term care (LTC) ownership groups and pharmacy chains C-suite executives by establishing mutual value added propositions. Led and managed all key accounts negotiations, agreements and projects implementation

• Create an entire influence network across key long-term care, pharmacy accounts to drive advocacy and sales
• Secured partnerships covering over 14,000 long-term care beds in QC/ON; led implementation of over 300 professional activities in LTC homes
• Developed a Health & Wellness program to reduce care gap for patients suffering from Osteoporosis, Alzheimer and Hypertension which has set the standard for future partnerships in the long term care market at Novartis
• 2010: ISE, International Sales Excellence Award (granted to 0.5% of the highest performers from around the globe)
• 2012: Customer First Challenging Winning Idea. Developed an innovative pharmacy-LTC customer solution program to drive $1.1M in sales for Novartis and avoid loss of $18M contract for Sandoz over 3 years

• GP representative - Alzheimer, Osteoporosis, Cardiovascular
• Specialty representative - Cardiovascular (McGILL)
• Developed and executed unique innovative sales strategies such as memory testing clinic in retirement homes exceeded sales targets in less than 8 months

• Dermatology/ COPD : GP + Specialty sales representative CHUM
• Achieved consistent sales growth by cultivating strong relationships with key decision-makers within the medical community. Annual sales growth of 38 % vs Budget